These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 36600626)
1. Adhesion Molecules as Prognostic Biomarkers in Coronary Artery Disease. Sagris M; Theofilis P; Antonopoulos AS; Oikonomou E; Simantiris S; Papaioannou S; Tsioufis C; Tousoulis D Curr Top Med Chem; 2023; 23(6):481-490. PubMed ID: 36600626 [TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
3. Relationship Between Coronary Artery Calcium and Atherosclerosis Progression Among Patients With Suspected Coronary Artery Disease. Hollenberg EJ; Lin F; Blaha MJ; Budoff MJ; van den Hoogen IJ; Gianni U; Lu Y; Bax AM; van Rosendael AR; Tantawy SW; Andreini D; Cademartiri F; Chinnaiyan K; Choi JH; Conte E; de Araújo Gonçalves P; Hadamitzky M; Maffei E; Pontone G; Shin S; Kim YJ; Lee BK; Chun EJ; Sung JM; Gimelli A; Lee SE; Bax JJ; Berman DS; Sellers SL; Leipsic JA; Blankstein R; Narula J; Chang HJ; Shaw LJ JACC Cardiovasc Imaging; 2022 Jun; 15(6):1063-1074. PubMed ID: 35680215 [TBL] [Abstract][Full Text] [Related]
4. Echoing Plaque Activity of the Coronary and Intracranial Arteries in Patients With Stroke. Chung JW; Bang OY; Lee MJ; Hwang J; Cha J; Choi JH; Choe YH Stroke; 2016 Jun; 47(6):1527-33. PubMed ID: 27217505 [TBL] [Abstract][Full Text] [Related]
5. Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role. Chen Y; Wang X; Yang C; Su X; Yang W; Dai Y; Han H; Jiang J; Lu L; Wang H; Chen Q; Jin W Atherosclerosis; 2019 Feb; 281():78-88. PubMed ID: 30658195 [TBL] [Abstract][Full Text] [Related]
6. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin. Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427 [TBL] [Abstract][Full Text] [Related]
7. C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis. Lu L; Zhang RY; Wang XQ; Liu ZH; Shen Y; Ding FH; Meng H; Wang LJ; Yan XX; Yang K; Wang HB; Pu LJ; Zhang Q; Chen QJ; De Caterina R; Shen WF Eur Heart J; 2016 Jun; 37(22):1762-71. PubMed ID: 26705391 [TBL] [Abstract][Full Text] [Related]
8. Research on the correlation between activating transcription factor 3 expression in the human coronary artery and atherosclerotic plaque stability. Peng J; Le CY; Xia B; Wang JW; Liu JJ; Li Z; Zhang QJ; Zhang Q; Wang J; Wan CW BMC Cardiovasc Disord; 2021 Jul; 21(1):356. PubMed ID: 34320932 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease. Kryczka KE; Kruk M; Demkow M; Lubiszewska B Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356659 [TBL] [Abstract][Full Text] [Related]
10. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture. Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice. Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075 [TBL] [Abstract][Full Text] [Related]
12. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability. Olejarz W; Łacheta D; Kubiak-Tomaszewska G Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486345 [TBL] [Abstract][Full Text] [Related]
13. Impact of concomitant coronary artery disease on atherosclerotic plaques in the aortic arch in patients with severe aortic stenosis. Fujita S; Sugioka K; Matsumura Y; Ito A; Hozumi T; Hasegawa T; Hanatani A; Naruko T; Ueda M; Yoshiyama M Clin Cardiol; 2013 Jun; 36(6):352-7. PubMed ID: 23585299 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability. Erbel C; Wolf A; Lasitschka F; Linden F; Domschke G; Akhavanpoor M; Doesch AO; Katus HA; Gleissner CA Int J Cardiol; 2015; 186():219-25. PubMed ID: 25828120 [TBL] [Abstract][Full Text] [Related]
15. Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis. Ragino YI; Striukova EV; Murashov IS; Polonskaya YV; Volkov AM; Kurguzov AV; Chernjavskii AM; Kashtanova EV BMC Res Notes; 2019 Jun; 12(1):336. PubMed ID: 31196144 [TBL] [Abstract][Full Text] [Related]
16. Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction. Radecke CE; Warrick AE; Singh GD; Rogers JH; Simon SI; Armstrong EJ Thromb Haemost; 2015 Mar; 113(3):605-16. PubMed ID: 25413339 [TBL] [Abstract][Full Text] [Related]
17. Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease. Samah N; Ugusman A; Hamid AA; Sulaiman N; Aminuddin A Mediators Inflamm; 2023; 2023():9715114. PubMed ID: 37457745 [TBL] [Abstract][Full Text] [Related]
18. Clinical risk factors and atherosclerotic plaque extent to define risk for major events in patients without obstructive coronary artery disease: the long-term coronary computed tomography angiography CONFIRM registry. van Rosendael AR; Bax AM; Smit JM; van den Hoogen IJ; Ma X; Al'Aref S; Achenbach S; Al-Mallah MH; Andreini D; Berman DS; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Chinnaiyan K; Chow BJW; Cury RC; DeLago A; Feuchtner G; Hadamitzky M; Hausleiter J; Kaufmann PA; Kim YJ; Leipsic JA; Maffei E; Marques H; de Araújo Gonçalves P; Pontone G; Raff GL; Rubinshtein R; Villines TC; Gransar H; Lu Y; Peña JM; Lin FY; Shaw LJ; Min JK; Bax JJ Eur Heart J Cardiovasc Imaging; 2020 May; 21(5):479-488. PubMed ID: 32065624 [TBL] [Abstract][Full Text] [Related]
19. Facilitatory effects of fetuin-A on atherosclerosis. Naito C; Hashimoto M; Watanabe K; Shirai R; Takahashi Y; Kojima M; Watanabe R; Sato K; Iso Y; Matsuyama TA; Suzuki H; Ishibashi-Ueda H; Watanabe T Atherosclerosis; 2016 Mar; 246():344-51. PubMed ID: 26828753 [TBL] [Abstract][Full Text] [Related]
20. Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease. Lu L; Wang YN; Li MC; Wang HB; Pu LJ; Niu WQ; Meng H; Yang EL; Zhang RY; Zhang Q; Zhao Q; Chen QJ; De Caterina R; Shen WF Eur Heart J; 2012 Sep; 33(18):2297-306. PubMed ID: 22645192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]